Arthur Beacham, DO
Interventional Pain Medicine · Oklahoma City, OKNPI 1144474362
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,275 of the $3,602 with a category attached, or 63.2%. 13 manufacturers reported payments, led by Relievant Medsystems, Inc. at 26.6% of the total. Reporting peaked in 2023 at $958 and has fallen 80.2% since, to $190 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in OK, where the typical reported total is $5,016.
Across 48 payments — averaging $75.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Relievant Medsystems, Inc.$958
- MML US, Inc.$763
- Abbott$593
- Boston Scientific$414
- Stryker$170
- Nevro Corp.$162
- plus $542 from 7 others
What the payments were for
- Travel & lodging$1,32737%
- Food & beverage$2,27563%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Relievant Medsystems, Inc. | 7 | $958 |
| MML US, Inc. | 3 | $763 |
| Abbott | 17 | $593 |
| Boston Scientific | 7 | $414 |
| Stryker | 1 | $170 |
| Nevro Corp. | 1 | $162 |
| Si-bone, Inc. | 1 | $160 |
| Daiichi Sankyo Inc. | 1 | $106 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $100 |
| Pacira Therapeutics, Inc. | 4 | $64 |
| Medtronic | 2 | $56 |
| Vertex | 2 | $45 |
| Amgen | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$3,755
- ReActiv8$763
- Neuromodulation Dspsbls and Accs$268
- CHESAPEAKE STABILIZATION SYSTEM$170
- Omnia$162
- Morphabond ER$106
How this compares
$3,602 in reported general payments places this provider in the 40th percentile of 27 interventional pain medicine providers in Oklahoma.
See all interventional pain medicine providers in Oklahoma →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 22 | $9,429 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 225 | $7,810 |
| Nucynta ErTapentadol Hcl | 11 | $6,935 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 137 | $4,030 |
| Gabapentin | 44 | $407 |
| Oxycodone Hcl | 12 | $346 |
| Cyclobenzaprine Hcl | 11 | $326 |
| Tizanidine Hcl | 28 | $296 |
| Morphine Sulfate ErMorphine Sulfate | 13 | $272 |
| Methadone Hcl | 12 | $225 |
| Tramadol Hcl | 22 | $210 |
| Methylprednisolone | 11 | $72 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Oklahoma City
- Brandon ValantineOklahoma City$9K
- Justin PorterOklahoma City$8K
- Blake ChristensenOklahoma City$6K
- Shawn EllisOklahoma City$6K
- Nathan OverbeyOklahoma City$5K
- Ahmed AmayemOklahoma City$5K
- Peyton JohnsonOklahoma City$5K
- Patrick PrevoOklahoma City$4K
- Timothy CramerOklahoma City$3K
- Sanaa KarimOklahoma City$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.